Encryption for high efficiency video coding with video adaptation capabilities

Video encryption techniques enable applications like digital rights management and video scrambling. Applying encryption on the entire video stream can be computationally costly and prevents advanced video modifications by an untrusted middlebox in the network, like splicing, quality monitoring, watermarking, and transcoding. Therefore, encryption techniques are proposed which influence a small amount of the video stream while keeping the video compliant with its compression standard, High Efficiency Video Coding. Encryption while guaranteeing standard compliance can cause degraded compression efficiency, so depending on their bitrate impact, a selection of encrypted syntax elements should be made. Each element also impacts the quality for untrusted decoders differently, so this aspect should also be considered. In this paper, multiple techniques for partial video encryption are investigated, most of them having a low impact on rate-distortion performance and having a broad range in scrambling performance(1)

Lawson criterion for ignition exceeded in an inertial fusion experiment

For more than half a century, researchers around the world have been engaged in attempts to achieve fusion ignition as a proof of principle of various fusion concepts. Following the Lawson criterion, an ignited plasma is one where the fusion heating power is high enough to overcome all the physical processes that cool the fusion plasma, creating a positive thermodynamic feedback loop with rapidly increasing temperature. In inertially confined fusion, ignition is a state where the fusion plasma can begin "burn propagation" into surrounding cold fuel, enabling the possibility of high energy gain. While "scientific breakeven" (i.e., unity target gain) has not yet been achieved (here target gain is 0.72, 1.37 MJ of fusion for 1.92 MJ of laser energy), this Letter reports the first controlled fusion experiment, using laser indirect drive, on the National Ignition Facility to produce capsule gain (here 5.8) and reach ignition by nine different formulations of the Lawson criterion

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Efficient depth-aware image deformation adaptation for curved screen displays

The curved screen has attracted considerable attentions in recent years, since it enables to enlarge the view angle and to enhance the immersive perception for users. However, existing curved surface projections are frequently prone to geometric distortion or loss of content. This paper presents a content-aware and depth-aware image adaptation solution for curved displays. An efficient optimization approach of image deformation is proposed to preserve local scene content and to minimize scene geometry distortion. To follow the original 3D perception of objects in different depth layers, the depth information is re-mapped for individual content scaling. Objective evaluation results reveal that our approach can effectively preserve foreground objects. We also perform a subjective evaluation of the proposed solution, and compare it to two alternative mapping methods, which are tested on different curvatures on both a traditional screen and an ad-hoc curvature-controllable curved display. Experimental results demonstrate that our approach outperforms other existing mapping methods for immersive display of rectangle images on curved screens